These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29 related articles for article (PubMed ID: 6703245)
1. Contribution of central nitric oxide to the regulation of blood pressure and sodium balance in DOCA-salt hypertension. Seto S; Nagao S; Ozeki S; Tetsuo H; Akahoshi M; Yano K J Cardiovasc Pharmacol; 2006 May; 47(5):680-5. PubMed ID: 16775508 [TBL] [Abstract][Full Text] [Related]
2. N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension. Tian N; Rose RA; Jordan S; Dwyer TM; Hughson MD; Manning RD J Hypertens; 2006 Nov; 24(11):2263-70. PubMed ID: 17053549 [TBL] [Abstract][Full Text] [Related]
3. Abnormal regulation of cytosolic calcium and pH in platelets of Sabra rats in early phases of salt hypertension development. Zicha J; Kunes J; Ben-Ishay D; Devynck MA Can J Physiol Pharmacol; 1996 Nov; 74(11):1222-8. PubMed ID: 9028581 [TBL] [Abstract][Full Text] [Related]
4. [Sodium and hypertension]. de Wardener HE Arch Mal Coeur Vaiss; 1996 Sep; 89 Spec No 4():9-15. PubMed ID: 8952809 [TBL] [Abstract][Full Text] [Related]
5. Volume sensitive hypertension and the digoxin-like factor. Reversal by a Fab directed against digoxin in DOCA-salt hypertensive rats. Krep H; Price DA; Soszynski P; Tao QF; Graves SW; Hollenberg NK Am J Hypertens; 1995 Sep; 8(9):921-7. PubMed ID: 8541008 [TBL] [Abstract][Full Text] [Related]
6. Oxidant stress and blood pressure responses to angiotensin II administration in rats fed varying salt diets. Pech V; Sikka SC; Sindhu RK; Vaziri ND; Majid DS Am J Hypertens; 2006 May; 19(5):534-40. PubMed ID: 16647629 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of renal eNOS by high-sodium diet facilitates hypertension in doxorubicin-treated rats through enhanced oxidative stress. Hirai T; Okumura K; Nishimoto Y; Shumiya T; Murakami R; Takahashi R; Asai T; Murakami H; Numaguchi Y; Matsui H; Murohara T Toxicology; 2006 Aug; 225(2-3):81-9. PubMed ID: 16870316 [TBL] [Abstract][Full Text] [Related]
8. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. Manunta P; Rogowski AC; Hamilton BP; Hamlyn JM J Hypertens; 1994 May; 12(5):549-60. PubMed ID: 7930555 [TBL] [Abstract][Full Text] [Related]
9. Salt and essential hypertension. Nugent CA Ariz Med; 1977 Jan; 34(1):29-32. PubMed ID: 836166 [No Abstract] [Full Text] [Related]
13. Salt and high blood pressure. McGuffin WL Ala J Med Sci; 1984 Jan; 21(1):20-5. PubMed ID: 6703245 [No Abstract] [Full Text] [Related]
14. The time course of salt-induced hypertension, and why it matters. Van Vliet BN; Montani JP Int J Obes (Lond); 2008 Dec; 32 Suppl 6():S35-47. PubMed ID: 19079278 [TBL] [Abstract][Full Text] [Related]
15. Recombinant adeno-associated virus-mediated human kallikrein gene therapy prevents high-salt diet-induced hypertension without effect on basal blood pressure. Yan JT; Wang T; Li J; Xiao X; Wang DW Acta Pharmacol Sin; 2008 Jul; 29(7):808-14. PubMed ID: 18565278 [TBL] [Abstract][Full Text] [Related]